Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-23-056706
Filing Date
2023-07-13
Accepted
2023-07-13 14:28:58
Documents
6
Effectiveness Date
2023-07-13

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea181761-s8_immucell.htm S-8 50227
2 OPINION OF PIERCE ATWOOD LLP ea181761ex5_immucell.htm EX-5 9905
3 CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM, WIPFLI LLP ea181761ex23-2_immucell.htm EX-23.2 2224
4 FILING FEE TABLE ea181761ex-fee_immucell.htm EX-FILING FEES 10357
5 GRAPHIC ex5_001.jpg GRAPHIC 13637
6 GRAPHIC ex5_002.jpg GRAPHIC 10428
  Complete submission text file 0001213900-23-056706.txt   107086
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-273227 | Film No.: 231086497
SIC: 2835 In Vitro & In Vivo Diagnostic Substances